Tokio Marine Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 2025 Q3 | $1.22M | Sell |  | |||||
| 2025 Q2 | $1.3M | Buy |  | |||||
| 2025 Q1 | $1.59M | Buy |  | |||||
| 2024 Q4 | $1.47M | Buy |  | |||||
| 2024 Q3 | $1.48M | Buy |  | |||||
| 2024 Q2 | $1.72M | Buy |  | |||||
| 2024 Q1 | $1.79M | Sell |  | |||||
| 2023 Q4 | $2.04M | Sell |  | |||||
| 2023 Q3 | $1.9M | Sell |  | |||||
| 2023 Q2 | $1.95M | Sell |  | |||||
| 2023 Q1 | $2.28M | Buy |  | |||||
| 2022 Q4 | $2.36M | Sell |  | |||||
| 2022 Q3 | $1.99M | Buy |  | |||||
| 2022 Q2 | $1.92M | Sell |  | |||||
| 2022 Q1 | $2.17M | Buy |  | |||||
| 2021 Q4 | $2.41M | Buy |  | |||||
| 2021 Q3 | $1.99M | Sell |  | |||||
| 2021 Q2 | $2.15M | Sell |  | |||||
| 2021 Q1 | $2.01M | Buy |  | |||||
| 2020 Q4 | $2.31M | Sell |  | |||||
| 2020 Q3 | $2.06M | Sell |  | |||||
| 2020 Q2 | $3.57M | Sell |  | |||||
| 2020 Q1 | $2.53M | Buy |  | |||||
| 2019 Q4 | $2.52M | Buy |  | |||||
| 2019 Q3 | $2M | Buy |  | |||||
| 2019 Q2 | $2.33M | Buy |  | |||||
| 2019 Q1 | $2.41M | Buy |  | |||||
| 2018 Q4 | $2.3M | Buy |  | |||||
| 2018 Q3 | $2.61M | Sell |  | |||||
| 2018 Q2 | $2.54M | Sell |  | |||||
| 2018 Q1 | $2.22M | Sell |  | |||||
| 2017 Q4 | $2.48M | Sell |  | |||||
| 2017 Q3 | $2.63M | Sell |  | |||||
| 2017 Q2 | $2.63M | Sell |  | |||||
| 2017 Q1 | $2.7M | Sell |  | |||||
| 2016 Q4 | $3.15M | Sell |  | |||||
| 2016 Q3 | $3.62M | Sell |  | |||||
| 2016 Q2 | $3.22M | Sell |  | |||||
| 2016 Q1 | $3.42M | Buy |  | |||||
| 2015 Q4 | $3.98M | Sell |  | |||||
| 2015 Q3 | $4.15M | Sell |  | |||||
| 2015 Q2 | $6M | Buy |  | |||||
| 2015 Q1 | $3.72M | Sell |  | |||||
| 2014 Q4 | $4.39M | Sell |  | |||||
| 2014 Q3 | $5.16M | Sell |  | |||||
| 2014 Q2 | $4.56M | Buy |  | |||||
| 2014 Q1 | $4.18M | Sell |  | |||||
| 2013 Q4 | $4.47M | Sell |  | |||||
| 2013 Q3 | $4.82M | Sell |  | |||||
| 2013 Q2 | $4.21M | Buy |  |